AACR cancer progress report reveals 33 percent decrease in cancer death rate, 1990 to 2020

Australia News News

AACR cancer progress report reveals 33 percent decrease in cancer death rate, 1990 to 2020
Australia Latest News,Australia Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

The age-adjusted overall cancer death rate in the United States decreased by 33 percent from 1991 to 2020, according to the annual AACR Cancer Progress Report 2023 published online Sept. 13 by the American Association for Cancer Research. The annual report provides the latest statistics on cancer etiology, mortality, and survivorship, as well as updates and context regarding the latest research in cancer.

, and four new T-cell engaging bispecific antibodies for hematologic malignancies. In addition, two new imaging agents were approved and the use of 12 previously approved anticancer therapeutics were expanded.

Between 1991 and 2020, the age-adjusted overall cancer death rate in the United States decreased by 33 percent, resulting in an estimated 3.8 million cancer deaths averted due in large part to advances in prevention, early detection, and treatment. A 43 percent decline was seen in breast cancer mortality between 1989 and 2020, and the decrease in lung cancer mortality accelerated by 0.9 percent per year between 1995 and 2005 to nearly 5 percent per year between 2014 and 2020.

"It is our hope that this comprehensive resource will help to increase knowledge about the myriad diseases we call cancer as well as the innovative research that is improving and extending lives," Margaret Foti, Ph.D., M.D., the chief executive officer of the American Association for Cancer Research, said in a statement.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AACR Cancer Progress Report provides latest statistics on cancer research and treatmentAACR Cancer Progress Report provides latest statistics on cancer research and treatmentToday, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences-;primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI)-;remain vitally important to improving health and saving lives.
Read more »

Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cellsBreast cancer recurrence may be triggered by chemotherapy injury to non-cancer cellsA standard chemotherapy drug injures surrounding non-cancer cells, which can then awaken dormant cancer cells and promotes cancer growth, according to a new study publishing September 12 in the open access journal PLoS Biology by Ramya Ganesan of Emory University, US, and colleagues. The finding is important for understanding cancer recurrence and may point to important new targets to prevent it.
Read more »

Expert explains familial adenomatous polyposisExpert explains familial adenomatous polyposisCancer in the colon and cancer in the rectum, often referred to together as colorectal cancer, is the third most common cancer diagnosed in both men and women in the U.S. excluding skin cancers, according to the American Cancer Society.
Read more »

New trial shows promise of combination neoadjuvant immunotherapy for lung cancerNew trial shows promise of combination neoadjuvant immunotherapy for lung cancerPatients with stage 1–3 non-small cell lung cancer (NSCLC) given a combination immunotherapy prior to surgery (neoadjuvant) had a better major pathological response (10% or less residual cancer) when the cancer was removed than those who took a single immunotherapy agent alone, according to results of a novel multicenter phase 2 NeoCOAST platform trial that included two investigators from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Institute for Cancer Immunotherapy.
Read more »

US drug overdose deaths more than quadrupled from 1999 to 2020, study findsUS drug overdose deaths more than quadrupled from 1999 to 2020, study findsThe United States is experiencing its highest overall death rates in more than a century, fueled in part by drug overdose mortality. The origins of the current epidemic are due, at least in part, to a 1986 World Health Organization pronouncement that pain treatment is a universal right. As such, cancer pain treatment guidelines were developed, which included the provision of opioids. In 1995, OxyContin was approved for the management of pain, paving the way for widespread prescription of opioids.
Read more »

Study: Drug overdose deaths in the U.S. more than quadrupled from 1999 to 2020Study: Drug overdose deaths in the U.S. more than quadrupled from 1999 to 2020The United States is experiencing its highest overall death rates in more than a century, fueled in part by drug overdose mortality. The origins of the current epidemic are due, at least in part, to a 1986 World Health Organization pronouncement that pain treatment is a universal right.
Read more »



Render Time: 2025-02-26 23:46:10